A biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics, its preparation method and application
By constructing a dynamic cross-linked composite hydrogel scaffold, and utilizing the biomimetic scaffold formed by the reaction of aldehyde-modified carboxylated polysaccharide macromolecules and calcium peroxide nanoparticles, the problem of limited materials and poor repair effect in bone defect treatment has been solved. It achieves spontaneous mechanical strengthening and oxygen release characteristics, promotes macrophage polarization and BMSC differentiation in the bone repair process, and improves the efficiency of bone defect repair.
Patent Information
- Application Number
- CN202611467707.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-20
- Publication Date
- 2026-11-10
AI Technical Summary
Treatment of bone defects faces challenges such as limited donor sites for autologous bone transplantation, risks of immune rejection and disease transmission associated with allogeneic and xenogeneic bone transplantation, and limited effectiveness of existing materials in bone repair.
A first-layer hydrogel network is formed by reacting aldehyde-modified carboxylated polysaccharide macromolecules with natural macromolecules containing amine groups through a Schiff base reaction. Then, a second-layer network is constructed by slowly releasing Ca2+ from monophenol or polyphenol-coated calcium peroxide nanoparticles and chelating it with the aldehyde-modified carboxylated polysaccharide macromolecules. This results in a dynamically cross-linked composite hydrogel scaffold, achieving spontaneous mechanical reinforcement and oxygen release characteristics.
After implantation, the scaffold can dynamically change from soft to hard to match the mechanical needs of different stages of bone repair, promote macrophage polarization to the anti-inflammatory M2 type, promote BMSCs to osteogenic differentiation, improve the efficiency of bone defect repair, and accelerate bone repair in a comprehensive and synergistic manner through sustained release of Ca2+ and oxygen release functions.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biomedical engineering materials technology, specifically relating to a biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics, its preparation method, and its application. Background Technology
[0002] While bone tissue possesses the ability to repair itself, this ability has its limits, especially for bone defects caused by various diseases, severe trauma, infections, malignant tumors, and osteoporotic fractures. Therefore, the clinical treatment of bone defects still faces many challenges. Autologous bone transplantation is the "gold standard" for treating bone defects; however, the availability of donor sites is limited, and both allogeneic and xenogeneic bone transplants carry risks of immune rejection and disease transmission, thus restricting their clinical application. Summary of the Invention
[0003] In view of this, the present invention provides a biomimetic scaffold with spontaneous mechanical strengthening and oxygen release characteristics. The present invention constructs a biomimetic scaffold with matrix mechanical changes to adapt to the bone defect repair process, and at the same time has anti-inflammatory and oxygen release functions, which can play a highly efficient role in promoting the repair of bone defects.
[0004] This invention provides a method for preparing a bionic scaffold, comprising the following steps: A biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics is obtained by chemically reacting aldehyde-modified carboxylated polysaccharide macromolecules, natural macromolecules containing amine groups, and calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
[0005] Preferably, the method for preparing the calcium peroxide nanoparticles coated with monophenols and / or polyphenols includes the following steps: Calcium peroxide nanoparticles were prepared by biomimetic mineralization reaction using calcium ions. The calcium peroxide nanoparticles are subjected to an oxidative self-polymerization reaction with monophenols and / or polyphenols to obtain calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
[0006] Preferably, the monophenol comprises at least one of the following: dopamine, norepinephrine, epinephrine, and hydroxytyrosol; The polyphenols include at least one of the following: tannic acid, gallic acid, epigallocatechin gallate, and catechin.
[0007] Preferably, the method for preparing the aldehyde-modified carboxylated polysaccharide macromolecule includes the following steps: Under light-protected conditions, the aldehyde modifier and carboxylated polysaccharide macromolecules are subjected to an oxidation reaction to obtain aldehyde-modified carboxylated polysaccharide macromolecules.
[0008] Preferably, the mass ratio of the carboxylated polysaccharide macromolecule to the aldehyde modifier is 4:1~3; The carboxylated polysaccharide macromolecules include at least one of the following: sodium alginate, pectin, hyaluronic acid, and gellan gum; The aldehyde-modifying agent includes sodium periodate.
[0009] Preferably, the amino-containing natural macromolecules include at least one of the following: chitosan, chitosan oligosaccharide, polylysine, and gelatin.
[0010] Preferably, in the chemical reaction system, the mass concentration of natural macromolecules containing amine groups is 10% to 50%, the mass concentration of aldehyde-modified carboxylic polysaccharide macromolecules is 10% to 50%, and the mass concentration of calcium peroxide nanoparticles coated with monophenols and / or polyphenols is 0.2% to 5%.
[0011] This invention provides a biomimetic scaffold prepared by the aforementioned method.
[0012] This invention provides a medical material for bone defect repair, which is made of the aforementioned bionic scaffold.
[0013] This invention provides the application of the biomimetic scaffold in the preparation of medical materials for bone injury repair.
[0014] This invention provides a method for preparing a biomimetic scaffold, which has the following advantages compared with the prior art: 1) The biomimetic scaffold constructed in this invention is hydrogel-like. First, a first-layer hydrogel network is formed through a Schiff base reaction between the amine groups in a natural macromolecule containing amine groups and the aldehyde groups in an aldehyde-modified carboxylated polysaccharide macromolecule. Then, calcium peroxide nanoparticles encapsulated in monophenols or polyphenols slowly release Ca2+. 2+ The scaffold's mechanical strength is significantly enhanced by ion chelation with the carboxyl groups in aldehyde-modified carboxylated polysaccharide macromolecules to construct a second network. This method enables the biomimetic scaffold to dynamically transform from soft to hard after implantation, matching the mechanical needs of different stages of bone repair: in the early stage of repair, the scaffold promotes macrophage polarization towards the anti-inflammatory M2 type; in the later stage of repair, it further promotes the differentiation of BMSCs towards osteogenic direction, thereby efficiently accelerating the repair process of bone defects. 2) The polyphenol-encapsulated calcium peroxide nanoparticles constructed in this invention not only release Ca... 2+ The biomimetic scaffold enhances the mechanical properties of the bone to promote bone repair, while also possessing the dual biological functions of scavenging reactive oxygen species (promoting macrophage polarization to M2 type) and releasing oxygen (promoting angiogenesis), thereby comprehensively and synergistically accelerating bone defect repair. 3) The raw materials used in the method of the present invention are natural and non-toxic materials that have good biocompatibility and hydrophilicity while maintaining excellent biodegradability. Attached Figure Description
[0015] Figure 1The structural characterization results of CaO2 and CaO2@PDA particles are shown, where A is the SEM image, B is the particle size diagram, and C is the potential detection result. Figure 2 The results of performance testing of AG-CaO2@PDA hydrogel at different time points are shown in Figure A, where A is the stress-strain curve, B is the change in Young's modulus, and C is the G′ and G″ of AG-CaO2@PDA hydrogel at 0, 3, 7, and 10 days under a frequency scan of 0.1~100 rad / s. Figure 3 The results of AG-CaO2@PDA hydrogel at different time points are shown in A, where A is the AFM image (mechanical mode); B is the corresponding Young's modulus, scale bar = 1 μm. Figure 4 Oxygen release curves of hydrogel samples in PBS at different time points; Figure 5 The results show the effect of AG-CaO2@PDA hydrogel on RAW264.7 macrophages. A is a representative immunofluorescence microscopy image of CD86 and CD206 in RAW264.7 macrophages (scale bar = 50 μm); B-E are the relative mRNA expression levels of inflammation-related genes in RAW264.7 cells after treatment. P <0.05, P <0.01; P <0.001; Figure 6 The efficacy of AG-CaO2@PDA hydrogel in wound healing is shown in Figure A, which is a representative microscopic image from an in vitro wound healing (scratch) assay; Figures B and C show the quantitative analysis results of cell migration at different time points. P <0.05, P <0.01; P <0.001; Figure 7The results show the pharmacodynamic effects of AG-CaO2@PDA hydrogel on osteogenic bone marrow mesenchymal stem cells (BMSCs). Image A shows confocal immunofluorescence microscopy images of different hydrogel scaffolds, displaying the distribution of bone formation markers (RUNX2 and COL-1) in BMSCs (scale bar = 100 μm). Images B and C represent the relative mRNA transcription levels of bone formation-related genes (RUNX2 and COL-1) in BMSCs. Data are expressed as mean ± standard deviation (n = 3). p <0.05, p <0.01, p <0.001; Figure 8 To illustrate the efficacy of AG-CaO2@PDA hydrogel in an animal femoral defect model, A represents representative micro-CT 3D reconstructed images of the femoral defect site at 4 and 8 weeks post-surgery; BC represents quantitative micro-CT analysis (bone volume / tissue volume (BV / TV)) of newly formed bone tissue at 4 and 8 weeks post-surgery. P <0.05, P <0.01; P <0.001. Detailed Implementation
[0016] This invention provides a method for preparing a bionic scaffold, comprising the following steps: A biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics is obtained by chemically reacting aldehyde-modified carboxylated polysaccharide macromolecules, natural macromolecules containing amine groups, and calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
[0017] In this invention, calcium peroxide nanoparticles coated with monophenols and / or polyphenols can slowly release Ca. 2+ The properties of the aldehyde-modified carboxylated polysaccharide macromolecules allow for ion chelation with the carboxyl groups, constructing an in-situ first-layer network. The aldehyde-modified carboxylated polysaccharide macromolecules then rapidly cross-link with Schiff bases containing amine groups, forming another first-layer network, thus achieving progressive self-reinforcement of the scaffold's mechanical properties. The coated monophenols and / or polyphenols effectively scavenge reactive oxygen species, while the decomposition of calcium peroxide continuously provides oxygen.
[0018] In this invention, the method for preparing calcium peroxide nanoparticles coated with monophenols and / or polyphenols preferably includes the following steps: preparing calcium peroxide nanoparticles by biomimetic mineralization reaction of calcium ions. The calcium peroxide nanoparticles are subjected to an oxidative self-polymerization reaction with monophenols and / or polyphenols to obtain calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
[0019] In this invention, the monophenol preferably includes at least one of the following: dopamine, norepinephrine, epinephrine, and hydroxytyrosol or derivatives thereof. In one embodiment of this invention, dopamine hydrochloride is used as a representative monophenol to illustrate the role of monophenol-coated calcium peroxide nanoparticles in the preparation of biomimetic scaffolds. The polyphenol preferably includes at least one of the following: tannic acid, gallic acid, epigallocatechin gallate, and catechin.
[0020] In this invention, the biomimetic mineralization reaction preferably includes mixing a calcium ion-containing solution with polyethylene glycol under alkaline conditions, adding hydrogen peroxide dropwise, reacting under light-protected conditions, and collecting the precipitate as calcium peroxide nanoparticles. The calcium ions are formed by dissolving CaCl2 in water, with a concentration of 0.1 g / mL. The preferred mass ratio of CaCl2, the volume of polyethylene glycol, and the volume of ammonia is 0.6 g: 24 mL: 4 mL.
[0021] In this invention, the oxidative self-polymerization reaction is carried out under alkaline conditions, preferably with a pH of 11-12, and can be 11.5. The mass ratio of the calcium peroxide nanoparticles to monophenols or polyphenols, or to the total mass ratio of the calcium peroxide nanoparticles to monophenols and polyphenols, is 1.5-2.5:0.5-1.5, and can be 2:1. In the oxidative self-polymerization reaction, the solvent is a 10 mM, pH 8.5 Tris-HCl buffer solution. The working concentration of the calcium peroxide nanoparticles is preferably 1-3 mg / mL, and can be 2 mg / mL. The oxidative self-polymerization reaction time is preferably 5-7 h, and can be 6 h. After the reaction, the reaction solution is preferably subjected to solid-liquid separation, the solid phase is collected, washed, and dried to obtain calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
[0022] In this invention, the method for preparing the aldehyde-modified carboxylated polysaccharide macromolecule preferably includes the following steps: Under light-protected conditions, an aldehyde-modifying agent and a carboxylated polysaccharide macromolecule are subjected to an oxidation reaction to obtain an aldehyde-modified carboxylated polysaccharide macromolecule. The preferred mass ratio of the carboxylated polysaccharide macromolecule to the aldehyde-modifying agent is 4:1 to 3, and can be 4:2. The carboxylated polysaccharide macromolecule preferably includes at least one of the following: sodium alginate, pectin, hyaluronic acid, and gellan gum. In this embodiment, sodium alginate is used as a representative to illustrate the preparation method of the aldehyde-modified carboxylated polysaccharide molecule and the prepared biomimetic scaffold. The aldehyde-modifying agent preferably includes sodium periodate. The working concentration of sodium alginate is 4%. The working concentration of sodium periodate is 1.175 g / mL. The reaction temperature is 18 to 25°C, and can be 20°C. The reaction time is 20 to 26 h, and can be 22 to 24 h. After the reaction, a quenching reaction is performed by adding excess ethylene glycol and reacting for 2 h to quench the reaction. After the quenching reaction, purification is preferably performed. The purification method is preferably dialysis. The dialysis bag used for dialysis is a dialysis bag with a retention capacity of 3500 Da. The dialysis time is not less than 60 hours, and can be 70-75 hours. After dialysis, it is preferred to preserve the product by lyophilization.
[0023] In this invention, the amino-containing natural macromolecules preferably include at least one of the following: chitosan, chitosan oligosaccharide, polylysine, and gelatin. These natural macromolecular materials are non-toxic and have good safety profiles when implanted in vivo. In embodiments of this invention, chitosan, gelatin, and polylysine are used as representatives of natural macromolecules to prepare biomimetic scaffolds.
[0024] In this invention, in the chemical reaction system, the mass concentration of natural macromolecules containing amine groups is preferably 10%~50%, can be 12%~45%, can be 15%~40%, can be 20%~30%, and more preferably 25%. The mass concentration of the aldehyde-modified carboxylic polysaccharide macromolecule is preferably 10%~50%, can be 15%~40%, can be 20%~30%, and more preferably 25%. The mass concentration of calcium peroxide nanoparticles coated with monophenols and / or polyphenols is preferably 0.2%~5%, can be 0.3%~4%, can be 0.5%~3%, and more preferably 1%. The temperature of the chemical reaction is 25~35℃, and can be 30~33℃. The time of the chemical reaction is 25~35 min, and can be 30 min. During the chemical reaction, it is preferable to remove air bubbles by ultrasound to prevent the formation of air bubbles in the biomimetic scaffold.
[0025] This invention provides a biomimetic scaffold prepared by the aforementioned method. It is a dual-network dynamically cross-linked composite hydrogel biomimetic scaffold. The first network is a covalent network formed instantaneously by the Schiff base reaction. The second network is not formed in one step during preparation but is developed after implantation / molding along with the decomposition of CaO2@PDA and Ca... 2+It is released and undergoes ion chelation with the carboxyl groups in the aldehyde-modified carboxylated polysaccharide macromolecules, forming an ion cross-linking network that grows slowly in situ inside the material, creating a unique "mechanical spontaneous reinforcement" characteristic.
[0026] In this invention, the biomimetic scaffold is spherical in shape with a particle size distribution of 950~1250nm, and exhibits a significant negative charge in Zata potential detection. The biomimetic scaffold possesses good anti-inflammatory activity and excellent viscoelasticity, which can promote the differentiation of bone marrow mesenchymal stem cells (BMSCs) into bone.
[0027] This invention provides a medical material for bone defect repair, which is made of the aforementioned bionic scaffold.
[0028] In this invention, when the medical material is prepared, a specific model is set according to the modified bone injury site. When preparing the bionic scaffold, natural macromolecules containing amine groups and calcium peroxide nanoparticles coated with monophenols and / or polyphenols are respectively loaded into one syringe, and an aldehyde-modified carboxylic polysaccharide macromolecule solution is loaded into another syringe. Both are injected into the mold at the same time, stirred and mixed evenly at room temperature, and allowed to stand for reaction to obtain a bionic scaffold with spontaneous mechanical strengthening and oxygen release characteristics.
[0029] This invention provides the application of the biomimetic scaffold in the preparation of medical materials for bone injury repair.
[0030] In this invention, bone defect repair is an orderly and gradual process. In the early stages of bone repair, hematoma formation at the defect site leads to a blood clot, triggering an aseptic inflammatory response and releasing inflammatory factors. This causes macrophages to transform from the pro-inflammatory M1 type to the anti-inflammatory M2 type, a process completed within the first three days. Prolonged presence of large amounts of inflammatory factors (IL-1β, TNF-α, etc.) may prevent macrophages from successfully transforming from M1 to M2, thus inhibiting osteogenic differentiation. As the inflammatory phase nears its end, a large number of bone mesenchymal stem cells (BMSCs) migrate from peripheral blood and surrounding tissues to the bone defect site, accelerating osteoblast differentiation and bone repair. Related studies have shown that soft matrix (elastic modulus E: 4–8 kPa) promotes macrophage polarization towards the anti-inflammatory M2 type, while hard matrix (elastic modulus E: 33–49 kPa) tends towards the pro-inflammatory M1 type. Furthermore, studies have found that BMSCs primarily differentiate into adipocytes in hydrogels with an initial elastic modulus of 9 kPa, and into osteoblasts in hydrogels with an initial elastic modulus of 17 kPa. Therefore, constructing a viscoelastically enhanced matrix can better promote bone defect repair. This invention, by simulating the dynamic changes in matrix mechanics during bone repair, simultaneously endows the scaffold with anti-inflammatory and angiogenesis-promoting functions, thereby efficiently promoting bone defect repair.
[0031] The following detailed description, in conjunction with embodiments, illustrates a biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics, its preparation method, and its applications. However, these descriptions should not be construed as limiting the scope of protection of this invention.
[0032] The primer sequences for qPCR detection involved in the embodiments of the present invention are shown in Table 1.
[0033] Table 1 Primer Sequences
[0034] Example 1 A method for fabricating a biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics. Prepare a 0.1 g / mL CaCl2 solution. Add 24 mL of polyethylene glycol (PEG-200) and 4 mL of 1.0 M ammonia to 6 mL of CaCl2 solution and stir for 30 min. Then, add 3 mL of H2O2 (30% w / w) dropwise at a rate of 0.4 mL / min. React under light-protected conditions for 6 h to obtain a pale yellow solution (30% w / w). Subsequently, gradually add 0.1 M sodium hydroxide solution under continuous stirring to adjust the pH to 11.5, precipitating a white suspension. Collect the precipitate by centrifugation at 12000 rpm and wash twice with anhydrous ethanol to obtain calcium peroxide (CaO2) nanoparticles. Add 50 mg of CaO2 nanoparticles to 25 mL of Tris-HCl buffer (10 mM, pH 8.5) and sonicate for 5 min. Subsequently, 25 mg of dopamine hydrochloride was added, and the mixture was stirred continuously for 6 hours. The precipitate was collected by centrifugation and washed three times with deionized water to remove any unreacted substances. The precipitate was then dried to obtain PDA@CaO2 nanoparticles.
[0035] 4 g of sodium alginate (SA) was added to a 250 mL round-bottom flask, dissolved thoroughly with 100 mL of deionized water, and then wrapped in aluminum foil. 2.35 g of sodium periodate was dissolved in 20 mL of deionized water. The sodium periodate solution was slowly added dropwise using a constant-pressure dropping funnel while stirring at room temperature. After the addition was complete, the reaction was kept at room temperature in the dark for 24 h. Then, excess ethylene glycol was added, and the reaction was quenched by continuing for 2 h. The quenching was then performed by pouring the solution into a 3500 molecular weight dialysis bag and dialyzing for 72 h. The dialyzed product was lyophilized and stored to obtain aldehyde-modified sodium alginate (OSA).
[0036] 0.2 g of gelatin was dissolved in 1 mL of purified water, and then 20 mg of PDA@CaO2 nanoparticles were added and dispersed evenly to form solution A. 0.2 g of aldehyde-modified sodium alginate was dissolved in 1 mL of purified water to form component B. Components A and B were then stirred evenly, ultrasonicated to remove air bubbles, and placed at 30°C for 30 minutes to obtain the biomimetic scaffold (AG-CaO2@PDA).
[0037] Example 2 A method for fabricating a biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics. 0.6 g CaCl2 was dissolved in 6 mL of purified water. After complete dissolution, 24 mL of polyethylene glycol (PEG-200) and 4 mL of 1.0 M ammonia were added and stirred for 30 min. Then, 3 mL of H2O2 (30% w / w) was added dropwise at a rate of 0.4 mL / min. The reaction was carried out under light-protected conditions for 6 h to obtain a pale yellow solution (30% w / w). Subsequently, 0.1 M sodium hydroxide solution was gradually added under continuous stirring to adjust the pH to 11.5, resulting in a white suspension. The precipitate was collected by centrifugation at 12000 rpm and washed twice with anhydrous ethanol to obtain calcium peroxide (CaO2) nanoparticles. 50 mg of CaO2 nanoparticles were added to 25 mL of Tris-HCl buffer (10 mM, pH 8.5) and ultrasonically dispersed for 5 min. Then, 25 mg of dopamine hydrochloride was added and stirred continuously for 6 h. The precipitate was collected by centrifugation and washed three times with deionized water to remove any unreacted substances. After drying, PDA@CaO2 nanoparticles were obtained.
[0038] 4 g of sodium alginate (SA) was added to a 250 mL round-bottom flask, dissolved thoroughly with 100 mL of deionized water, and then wrapped in aluminum foil. 2.35 g of sodium periodate was dissolved in 20 mL of deionized water. The sodium periodate solution was slowly added dropwise using a constant-pressure dropping funnel while stirring at room temperature. After the addition was complete, the reaction was kept at room temperature in the dark for 24 h. Then, excess ethylene glycol was added, and the reaction was quenched by continuing for 2 h. The quenching was then performed by pouring the solution into a 3500 molecular weight dialysis bag and dialyzing for 72 h. The dialyzed product was lyophilized and stored to obtain aldehyde-modified sodium alginate (OSA).
[0039] 0.2 g of polylysine was dissolved in 1 mL of purified water, and then 20 mg of CaO2@PDA particles were added and dispersed evenly to form solution A. 0.2 g of aldehyde-modified sodium alginate was dissolved in 1 mL of purified water to form component B. Components A and B were then stirred evenly, ultrasonically removed air bubbles, and placed at 30°C for 30 minutes to obtain the biomimetic scaffold.
[0040] Example 3 A method for fabricating a biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics. 0.6 g CaCl2 was dissolved in 6 mL of purified water. After complete dissolution, 24 mL of polyethylene glycol (PEG-200) and 4 mL of 1.0 M ammonia were added and stirred for 30 min. Then, 3 mL of H2O2 (30% w / w) was added dropwise at a rate of 0.4 mL / min. The reaction was carried out under light-protected conditions for 6 h to obtain a pale yellow solution (30% w / w). Subsequently, 0.1 M sodium hydroxide solution was gradually added under continuous stirring to adjust the pH to 11.5, resulting in a white suspension. The precipitate was collected by centrifugation at 12000 rpm and washed twice with anhydrous ethanol to obtain calcium peroxide (CaO2) nanoparticles. 50 mg of CaO2 nanoparticles were added to 25 mL of Tris-HCl buffer (10 mM, pH 8.5) and ultrasonically dispersed for 5 min. Then, 25 mg of dopamine hydrochloride was added and stirred continuously for 6 h. The precipitate was collected by centrifugation and washed three times with deionized water to remove any unreacted substances. After drying, PDA@CaO2 nanoparticles were obtained.
[0041] Add 4g of pectin to a 250mL round-bottom flask, dissolve thoroughly in 100mL of deionized water, and wrap with aluminum foil. Dissolve 2.35g of sodium periodate in 20mL of deionized water. While stirring, slowly add the sodium periodate solution dropwise using a constant-pressure dropping funnel at room temperature. After the addition is complete, maintain the reaction at room temperature in the dark for 24 hours. Then, add excess ethylene glycol and continue the reaction for 2 hours to quench the reaction. After completion, pour the solution into a 3500 molecular weight dialysis bag and dialyze for 72 hours. Freeze-dry the dialyzed product to obtain aldehyde-modified pectin.
[0042] 0.2 g of chitosan was dissolved in 1 mL of purified water, and then 20 mg of PDA@CaO2 nanoparticles were added and dispersed evenly to form solution A. 0.2 g of aldehyde-modified pectin was dissolved in 1 mL of purified water to form component B. Components A and B were then stirred evenly, ultrasonically removed to remove air bubbles, and placed at 30°C for 30 minutes to obtain a biomimetic scaffold.
[0043] Comparative Example 1 A method for preparing a biomimetic scaffold 4 g of sodium alginate (SA) was added to a 250 mL round-bottom flask, dissolved thoroughly with 100 mL of deionized water, and then wrapped in aluminum foil. 2.35 g of sodium periodate was dissolved in 20 mL of deionized water. The sodium periodate solution was slowly added dropwise using a constant-pressure dropping funnel while stirring at room temperature. After the addition was complete, the reaction was kept at room temperature in the dark for 24 h. Then, excess ethylene glycol was added, and the reaction was quenched by continuing for 2 h. The quenching was then performed by pouring the solution into a 3500 molecular weight dialysis bag and dialyzing for 72 h. The dialyzed product was lyophilized and stored to obtain aldehyde-modified sodium alginate (OSA).
[0044] 0.2 g of gelatin was dissolved in 1 mL of purified water to form solution A, and then 10 mg of CaCl2 was added and dispersed evenly. 0.2 g of aldehyde-modified sodium alginate was dissolved in 1 mL of purified water to form component B. Components A and B were then stirred evenly, ultrasonicated to remove air bubbles, and placed at 30°C for 30 minutes to obtain the biomimetic scaffold (AG-soft).
[0045] Comparative Example 2 A method for preparing a biomimetic scaffold 4 g of sodium alginate (SA) was added to a 250 mL round-bottom flask, dissolved thoroughly with 100 mL of deionized water, and then wrapped in aluminum foil. 2.35 g of sodium periodate was dissolved in 20 mL of deionized water. The sodium periodate solution was slowly added dropwise using a constant-pressure dropping funnel while stirring at room temperature. After the addition was complete, the reaction was kept at room temperature in the dark for 24 h. Then, excess ethylene glycol was added, and the reaction was quenched by continuing for 2 h. The quenching was then performed by pouring the solution into a 3500 molecular weight dialysis bag and dialyzing for 72 h. The dialyzed product was lyophilized and stored to obtain aldehyde-modified sodium alginate (OSA).
[0046] 0.2 g of gelatin was dissolved in 1 mL of purified water to form solution A, and then 20 mg of CaCl2 was added and dispersed evenly. 0.2 g of aldehyde-modified sodium alginate was dissolved in 1 mL of purified water to form component B. Components A and B were then stirred evenly, ultrasonicated to remove air bubbles, and placed at 30°C for 30 minutes to obtain the biomimetic scaffold (AG-stiff).
[0047] Comparative Example 3 A method for preparing a biomimetic scaffold 0.6 g CaCl2 was dissolved in 6 mL of purified water. After complete dissolution, 24 mL of polyethylene glycol (PEG-200) and 4 mL of 1.0 M ammonia were added and stirred for 30 min. Then, 3 mL of H2O2 (30% w / w) was added dropwise at a rate of 0.4 mL / min. The reaction was carried out under light-protected conditions for 6 h to obtain a pale yellow solution (30% w / w). Subsequently, 0.1 M sodium hydroxide solution was gradually added under continuous stirring to adjust the pH to 11.5, and a white suspension precipitated. The precipitate was collected by centrifugation at 12000 rpm and washed twice with anhydrous ethanol to obtain calcium peroxide (CaO2) particles.
[0048] 4 g of sodium alginate (SA) was added to a 250 mL round-bottom flask, dissolved thoroughly with 100 mL of deionized water, and then wrapped in aluminum foil. 2.35 g of sodium periodate was dissolved in 20 mL of deionized water. The sodium periodate solution was slowly added dropwise using a constant-pressure dropping funnel while stirring at room temperature. After the addition was complete, the reaction was kept at room temperature in the dark for 24 h. Then, excess ethylene glycol was added, and the reaction was quenched by continuing for 2 h. The quenching was then performed by pouring the solution into a 3500 molecular weight dialysis bag and dialyzing for 72 h. The dialyzed product was lyophilized and stored to obtain aldehyde-modified sodium alginate (OSA).
[0049] 0.2 g of gelatin was dissolved in 1 mL of purified water to form solution A. 20 mg of CaO2 nanoparticles were then added and dispersed evenly. 0.2 g of aldehyde-modified sodium alginate was dissolved in 1 mL of purified water to form component B. Components A and B were then stirred evenly, ultrasonicated to remove air bubbles, and placed at 30°C for 30 minutes to obtain the biomimetic scaffold (AG-CaO2).
[0050] Example 4 Structural characterization of biomimetic scaffolds The PDA@CaO2 nanoparticles and CaO2 prepared in Examples 1-3 were characterized structurally. Specifically, scanning electron microscopy was used to detect the appearance, dynamic light scattering (DLS) was used to detect the particle size, and electrophoretic light scattering was used to detect the potential of each particle.
[0051] See results Figure 1 As shown in the figure, both CaO2 and PDA@CaO2 nanoparticles exhibit a regular spherical shape. The particle size distribution of PDA@CaO2 nanoparticles is 950–1250 nm, a relatively narrow range, indicating good particle uniformity. The particle size distribution of CaO2 is 300–1800 nm, a wider range. Potential testing results show that CaO2 exhibits a positive charge, while PDA@CaO2 nanoparticles show an overall negative charge.
[0052] Example 5 Stress and modulus performance testing of biomimetic scaffolds The stress of the AG-CaO2@PDA prepared in Examples 1-3 was measured at different time points. The macroscopic compressibility of each group of hydrogel samples was tested using an Instron 5966 high-low temperature dual-column universal testing machine (USA). All test samples were uniformly prepared as cylindrical specimens with a diameter of 10 mm and a thickness of approximately 3 mm. The compression test rate was set to 2 mm / min. Based on the measured compressive stress-strain curves, the Young's modulus of the samples was calculated using the slope of the linear strain range of 0-10%, quantitatively characterizing the macroscopic stiffness and compressibility of the hydrogel. The average value of the test results was calculated, and stress-strain curves were plotted.
[0053] Meanwhile, G′ and G″ of AG-CaO2@PDA were detected at different times during frequency scans of 0.1 to 100 rad / s.
[0054] See results Figure 2 As shown in the figure, the AG-CaO2@PDA hydrogel achieves a time-sequential dynamic enhancement of mechanical properties by leveraging the sustained-release properties of CaO2@PDA. The CaO2@PDA particles loaded in the system continuously and steadily release Ca... 2+ Free calcium ions gradually complex and crosslink with carboxylate groups in the hydrogel network, continuously improving the internal three-dimensional network structure. With prolonged culture time, the Young's modulus of the AG-CaO2@PDA hydrogel dynamically increased from the initial 22.5±3.4 kPa to 52.4±4.2 kPa; rheological test results also showed that its storage modulus and loss modulus continuously increased over time, proving that the elasticity and network stability of the hydrogel gradually improved.
[0055] Example 6 AFM and Young's modulus measurements of the biomimetic scaffold were performed using a Bruker MultiMode 8-HR atomic force microscope (AFM) in tapping mode to characterize the microscopic Young's modulus of the hydrogel surface. The test scanning area was set to 4 μm × 4 μm. The surface modulus distribution of the material was obtained through micromechanical testing, revealing the rigidity and mechanical homogeneity of the hydrogel at the microscale, which was corroborated by the macroscopic compression test results.
[0056] See results Figure 3 As shown in the figure, the micromechanical test results are highly consistent with the macroscopic compression test results. The surface modulus of the AG-CaO2@PDA hydrogel continuously increases with the culture time, gradually increasing from 19.6±4.4 kPa on day 0 to 61.8±6.1 kPa on day 10. In summary, this embodiment successfully constructed a dynamic stiffness hydrogel with time-dependent mechanical enhancement properties, which can effectively simulate the progressive mechanical maturation process of natural callus.
[0057] Example 7 Oxygen release performance testing of biomimetic scaffolds The prepared biomimetic scaffolds (25 mg / mL or 100 mg / mL) were immersed in phosphate-buffered saline (PBS, pH 7.4) and incubated at 37°C, with PBS solution serving as a blank control. Dissolved oxygen concentrations were measured at preset time points using a dissolved oxygen meter (Smart Sensor, China).
[0058] See results Figure 4As shown in the figure, the AG-CaO2 hydrogel system exhibits a significant oxygen burst release phenomenon, with an excessively rapid oxygen release rate and a short release cycle. The effective oxygen release duration can only be maintained for 7 days, which is insufficient to meet the oxygen supply requirements for long-term bone tissue repair. In contrast, the AG-CaO2@PDA hydrogel loaded with PDA-coated modified particles effectively solves the defect of uncontrolled oxygen release from pure CaO2. The PDA shell can form a physical barrier and slow-release regulation effect on the internal CaO2 active particles, greatly improving the oxygen release kinetics and effectively avoiding the microenvironmental disturbance caused by the instantaneous release of large amounts of oxygen, significantly improving the stability and sustainability of the oxygen release process. The modified composite hydrogel can extend the effective oxygen release cycle to 20 days, achieving long-term, stable, and sustained oxygen release. This excellent continuous oxygen supply characteristic can effectively improve the local hypoxic microenvironment at the bone defect site, ensure normal cell survival and proliferation, and provide a favorable biological microenvironment for angiogenesis, bone tissue remodeling and regeneration, thus aiding in bone defect repair.
[0059] Example 8 Anti-inflammatory testing of bionic scaffolds Immunofluorescence staining was used to observe the expression of cellular proteins on different hydrogel surfaces. Cells were directly seeded into 24-well plates with hydrogel scaffolds for culture. The RAW 264.7 macrophage seeding density was 1 × 10⁻⁶ cells / well. 4 Cells were cultured per well for 72 hours. After culture, the culture medium was aspirated, and the hydrogel samples carrying cells were thoroughly washed with PBS and fixed with 4% paraformaldehyde for 15 minutes. To achieve effective exposure of intracellular antigens, the cell membranes were permeabilized with 0.3% Triton X-100, followed by blocking with 5% bovine serum albumin (BSA) solution to reduce non-specific staining interference. After blocking, primary antibodies specific to each target protein were added at a dilution of 1:200, and the samples were incubated overnight at 4°C. RAW 264.7 macrophages were labeled with anti-INOS, anti-CD86, anti-Arg-1, and anti-CD206 antibodies to evaluate macrophage polarization phenotype. After primary antibody incubation and washing with PBS, FITC-labeled fluorescent secondary antibody (diluted 1:300) was added, and the samples were incubated at room temperature in the dark for 1 hour; the cell nuclei were then counterstained with DAPI. After all samples were processed, fluorescence images were acquired using a Nikon confocal laser scanning microscope for qualitative observation and analysis.
[0060] Real-time quantitative PCR (RT-qPCR) was used to detect gene expression by directly seeding cells onto the surface of 24-well plates coated with hydrogel samples. The seeding density of both RAW 264.7 macrophages and HUVEC cells was 4 × 10⁻⁶ cells / well. 4Cells were cultured at 100 cells / well for 72 hours. Two culture conditions were set up for RAW 264.7 macrophages: one without LPS and the other with 10 ng / mL LPS stimulation. After culture, total RNA was extracted from each group of cells using TRIzol reagent, and cDNA was synthesized by reverse transcription using a reverse transcription kit. A 10 μL reaction mixture was prepared using the TB Green Premix Ex Taq kit, and PCR amplification was performed on a CFX384 Touch real-time quantitative PCR system (Bio-Rad Laboratories, USA) in 384-well plates. Target genes included INOS, CD86, Arg-1, and CD206 (primers are shown in Table 1). The expression levels of each target gene were normalized using the housekeeping gene GAPDH as an internal control.
[0061] See results Figure 5 To simulate the inflammatory microenvironment in the early stages of bone defects, this embodiment used lipopolysaccharide (LPS) to stimulate RAW264.7 macrophages, inducing macrophage polarization towards the pro-inflammatory M1 phenotype. Immunofluorescence (IF) staining results showed that, compared to the high-elasticity AG-stiff hydrogel, the low-elasticity AG-soft hydrogel was more conducive to promoting macrophage polarization towards the anti-inflammatory M2 phenotype, as evidenced by the presence of the M1 macrophage marker CD86. + INOS + The percentage of positive cells decreased, and the M2 macrophage marker CD206 was observed. + Arg-1 + The proportion of positive cells increased. Among them, AG-CaO2@PDA hydrogel exhibited the most prominent anti-inflammatory effect, which can be attributed to the synergistic effect between the material's low mechanical modulus and its ability to scavenge reactive oxygen species (ROS).
[0062] The quantitative detection results of M1 biomarker genes CD86 and INOS, and M2 biomarker genes CD206 and Arg-1 by RT-qPCR were consistent with those observed by immunofluorescence phenotype. Figure 5 (BE). Intergroup statistical analysis showed that, compared with AG-stiff hydrogel, AG-soft hydrogel could upregulate the transcriptional level of M2 macrophage-related genes while inhibiting the expression of M1 macrophage-related genes. Among the four tested hydrogels, the AG-CaO2@PDA group had the highest expression level of M2 marker genes and the lowest expression level of M1 marker genes.
[0063] Example 9 Angiogenesis detection of biomimetic scaffolds Before conducting the indirect co-culture experiment for scratch healing, the hydrogel was pretreated by soaking it in complete culture medium for 24 hours. HUVECs were then cultured at a concentration of 1×10⁻⁶. 5Cells were seeded at a density of [number] cells / well in 6-well plates and cultured until confluence formed a continuous monolayer. A sterile 200 μL pipette tip was used to make vertical straight scratches on the surface of the cell monolayer. The plates were then thoroughly washed with PBS buffer to remove any detached cells. A culture-pretreated hydrogel was placed in a Transwell chamber with a dialysis membrane, and the chamber was then placed in the wells of a 6-well plate to construct an indirect co-culture system. The healing of the scratches was observed and recorded at 12 h and 24 h using a Nikon inverted microscope. Images were acquired for subsequent analysis of cell migration ability.
[0064] See results Figure 6 As shown in the figure, the Transwell indirect co-culture-scratch healing experiment was used to investigate the effect of soluble factors released by hydrogels in each group on the migration ability of human umbilical vein endothelial cells (HUVECs). Figure 6 Microscopic images of scratches at 0h, 12h, and 24h show that the scratch gaps in each group decreased to varying degrees with prolonged culture time. Quantitative statistical results at 12h showed that the scratch healing rates of the AG-soft and AG-stiff groups were relatively low, with no significant difference between the two groups; the healing rate of the AG-CaO2 group was significantly higher than that of the two static gel groups; the AG-CaO2@PDA group exhibited the highest cell migration level at 12h, significantly higher than the other three groups. P <0.05, P <0.001). At 24 hours of culture, the scratch healing rate of each group further increased. Static mechanically, the migration-promoting abilities of AG-soft and AG-stiff groups were limited; the AG-CaO2 group benefited from the oxygen release effect, significantly promoting HUVEC migration; while the AG-CaO2@PDA group had the highest scratch healing rate among the four groups, showing statistically significant differences compared to the other groups. P <0.05, P <0.01, P <0.001), the migration of endothelial cells to the scratch blank area was the most obvious.
[0065] Example 10 Osteogenesis detection of biomimetic scaffolds Immunofluorescence staining was used to observe the expression of cellular proteins on different hydrogel surfaces. Cells were directly seeded into 24-well plates containing hydrogel scaffolds for culture. The seeding density of BMSCs was 1×10⁻⁶. 4Cells were cultured in osteogenic induction medium for 7 days. After culture, the medium was removed, and the hydrogel samples carrying cells were thoroughly washed with PBS and fixed with 4% paraformaldehyde for 15 min. To achieve effective exposure of intracellular antigens, the cell membranes were permeabilized with 0.3% Triton X-100, followed by blocking with 5% bovine serum albumin (BSA) solution to reduce non-specific staining interference. After blocking, primary antibodies specific to each target protein at a dilution of 1:200 were added, and the samples were incubated overnight at 4°C. Osteogenic and adhesion-related proteins in BMSCs were detected using anti-RUNX2 and anti-COL-1 antibodies. After primary antibody incubation and washing with PBS, FITC-labeled fluorescent secondary antibody (diluted 1:300) was added, and the samples were incubated at room temperature in the dark for 1 h; then, the cell nuclei were counterstained with DAPI staining solution. After all samples were processed, fluorescence images were acquired using a Nikon confocal laser scanning microscope for qualitative observation and analysis.
[0066] To perform RT-qPCR expression analysis, cells were directly seeded onto the surface of a 24-well hydrogel. BMSCs were seeded at a density of 2 × 10⁶ cells per well. 4 Cells were seeded at a density of [number] cells and cultured in osteogenic induction medium for 7 days. Total RNA was extracted from each cell sample using TRIzol reagent, and cDNA was synthesized using a reverse transcription kit. Real-time PCR was performed using the TB Green Premix Ex Taq kit in a 10 μL reaction volume. Primers used are shown in Table 1. Amplification was performed in 384-well plates on a CFX384 Touch real-time PCR system (Bio-Rad, USA). Expression levels of target genes (RUNX2 and COL-1) were normalized using the housekeeping gene GAPDH as an internal standard.
[0067] See results Figure 7 As shown in the figure, immunofluorescence results revealed that the RUNX2 and COL-1 fluorescence signals of BMSCs on the surface of the static soft scaffold AG-soft were the weakest, indicating the lowest expression levels of osteogenic-related proteins. The osteogenic protein fluorescence signals of the static hard scaffold AG-stiff were significantly stronger than those of AG-soft, suggesting that higher matrix stiffness can promote osteogenic differentiation by activating osteoblast mechanical signaling pathways. The AG-CaO2 hydrogel, exhibiting a dynamic mechanical property of initial softness followed by hardness, showed further enhanced RUNX2 and COL-1 fluorescence expression, suggesting that Ca... 2+ Mediated dynamic sclerosis, synergistic with CaO2 oxygen supply, can significantly enhance osteogenic differentiation of BMSCs. The AG-CaO2@PDA composite hydrogel exhibits the strongest and most widespread osteogenic protein fluorescence signal on its surface, indicating the highest degree of osteogenic differentiation.
[0068] RT-qPCR results were consistent with immunofluorescence: the relative mRNA expression levels of RUNX2 and COL-1 showed an increasing trend of AG-soft < AG-stiff < AG-CaO2 < AG-CaO2@PDA, with the AG-CaO2@PDA group showing significantly higher RUNX2 and COL-1 expression levels than the other groups. These results further confirm at the gene transcription level that AG-CaO2@PDA hydrogel can effectively induce osteogenic differentiation of BMSCs and promote bone matrix deposition, providing an in vitro mechanistic basis for its efficient in vivo bone defect repair.
[0069] Example 11 Animal experiments verifying the bionic scaffold Rats were euthanized by injecting excessive amounts of sodium pentobarbital in batches at 4 and 8 weeks post-surgery, and femoral condyle tissue was harvested. The femur was carefully dissected using sterile scissors and forceps, and surrounding soft tissue was removed. Using the proximal femur as support, the distal femoral condyle was carefully removed, ensuring the integrity of the defect area. Intact femoral condyle bone tissue was harvested and placed in 4% paraformaldehyde fixative according to its number. Immediately after fixation for 48 hours, the tissue was sent for Micro-CT scanning. The obtained CT data were used to reconstruct the 3D structure using CTvox software (Bruker Micro-CT) and quantified using Prism to analyze the bone volume / total volume (BV / TV).
[0070] See results Figure 8 As shown in the figure, Micro-CT was used to perform three-dimensional reconstruction analysis of femoral condyle defects in rats at 4 and 8 weeks post-surgery. At 4 weeks post-surgery, the Control group had less bone volume and sparse trabeculae in the defect area, indicating limited repair; the AG-soft group showed some new bone formation, but the bone bridges had not yet closed, indicating limited repair; the AG-stiff group had significantly more trabeculae than the AG-soft group, but large gaps still existed in the defect area; the AG-CaO2 group had an increased number of trabeculae, but their distribution was uneven, and large bone defects remained in some areas; the AG-CaO2@PDA group had the most new bone volume, dense trabeculae distribution, and significantly better filling of the defect area than the other groups. At 8 weeks post-surgery, bone repair in the Control group was further enhanced, but the defect area was not yet fully healed; the AG-soft group showed an increase in trabecular bone compared to 4 weeks, but repair was still incomplete; the AG-stiff group showed the beginning of bone bridge formation and enhanced trabecular structure; the AG-CaO2 group showed an increase in the number of trabecular bone, but bone bridge formation was not as significant as in the AG-CaO2@PDA group; the AG-CaO2@PDA group showed the best repair effect, with new bone almost filling the defect area and significant trabecular continuity. BV / TV, the ratio of new bone volume to the total volume of the bone defect, reflects the degree of bone formation. At 4 weeks post-surgery, the Control group had the lowest BV / TV, while the AG-CaO2@PDA group had the highest. PThe result was <0.001, indicating that the combined effects of dynamic mechanics and polyphenol anti-inflammatory properties can effectively promote new bone formation. Eight weeks post-surgery, the BV / TV ratio in the AG-CaO2@PDA group further increased to 52.7±2.2%, while the ratios in the Control group, AG-soft group, AG-stiff group, and AG-CaO2 group were 28.2±2.0%, 40.1±2.9%, 41.6±2.8%, and 45.8±1.6%, respectively.
[0071] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A method for preparing a biomimetic scaffold, characterized in that, Includes the following steps: A biomimetic scaffold with spontaneous mechanical reinforcement and oxygen release characteristics is obtained by chemically reacting aldehyde-modified carboxylated polysaccharide macromolecules, natural macromolecules containing amine groups, and calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
2. The preparation method according to claim 1, characterized in that, The method for preparing calcium peroxide nanoparticles coated with monophenols and / or polyphenols includes the following steps: Calcium peroxide nanoparticles were prepared by biomimetic mineralization reaction using calcium ions. The calcium peroxide nanoparticles are subjected to an oxidative self-polymerization reaction with monophenols and / or polyphenols to obtain calcium peroxide nanoparticles coated with monophenols and / or polyphenols.
3. The preparation method according to claim 1, characterized in that, The monophenols include at least one of the following: dopamine, norepinephrine, epinephrine, and hydroxytyrosol; The polyphenols include at least one of the following: tannic acid, gallic acid, epigallocatechin gallate, and catechin.
4. The preparation method according to claim 1, characterized in that, The method for preparing the aldehyde-modified carboxylated polysaccharide macromolecule includes the following steps: Under light-protected conditions, the aldehyde modifier and carboxylated polysaccharide macromolecules are subjected to an oxidation reaction to obtain aldehyde-modified carboxylated polysaccharide macromolecules.
5. The preparation method according to claim 4, characterized in that, The mass ratio of the carboxylated polysaccharide macromolecule to the aldehyde modification agent is 4:1~3; The carboxylated polysaccharide macromolecules include at least one of the following: sodium alginate, pectin, hyaluronic acid, and gellan gum; The aldehyde-modifying agent includes sodium periodate.
6. The preparation method according to claim 1, characterized in that, The amino-containing natural macromolecules include at least one of the following: chitosan, chitosan oligosaccharide, polylysine, and gelatin.
7. The preparation method according to any one of claims 1 to 6, characterized in that, In the chemical reaction system, the mass concentration of natural macromolecules containing amine groups is 10-50%, the mass concentration of aldehyde-modified carboxylic polysaccharide macromolecules is 10-50%, and the mass concentration of calcium peroxide nanoparticles coated with monophenols and / or polyphenols is 0.2-5%.
8. A biomimetic scaffold prepared by the preparation method according to any one of claims 1 to 7.
9. A medical material for repairing bone defects, characterized in that, It is made from the bionic scaffold described in claim 8.
10. The application of the biomimetic scaffold of claim 8 in the preparation of medical materials for bone injury repair.
